| Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681) |
|---|
| 04/15/2010 | WO2010040252A1 Epothilone glycoside compounds, compositions containing epothilone glycoside compounds as active components and uses thereof |
| 04/15/2010 | US20100093984 Extraction method |
| 04/14/2010 | EP2174944A1 Polyene diester antibiotics |
| 04/14/2010 | CN101693732A Method for extracting and purifying natamycin |
| 04/14/2010 | CN101693731A Method for extracting purified plantarenaloside from herba lysimachiae, product of plantarenaloside and application of method |
| 04/14/2010 | CN101081860B Polyene antibiotic diester compound |
| 04/08/2010 | WO2010038842A1 Novel polyphenol compound |
| 04/07/2010 | EP2172457A2 Fredericamycin derivatives |
| 04/07/2010 | EP2170350A2 Substituted imidazoheterocycles |
| 04/07/2010 | CN1569869B Chinese chestnut flower flavone compounds |
| 04/07/2010 | CN101691390A 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 04/06/2010 | CA2445346C N-substituted pyrazole-o-glycoside derivatives and therapeutic agent for diabetes containing the same |
| 04/01/2010 | US20100081800 Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof |
| 03/31/2010 | CN101686989A substituted imidazoheterocycles |
| 03/31/2010 | CN101683353A Preparation method and application of flavone and flavan derivatives |
| 03/30/2010 | US7687470 Avermectin and avermectin monosaccharide substituted in the 4″- and 4″ position respectively |
| 03/30/2010 | CA2467611C Azithromycin dosage forms with reduced side effects |
| 03/30/2010 | CA2328289C Method for laminaribiose synthesis |
| 03/25/2010 | US20100076183 Protected monomer and method of final deprotection for rna synthesis |
| 03/25/2010 | US20100075912 Novel morphine derivatives |
| 03/23/2010 | US7683163 Colchicoside analogues |
| 03/23/2010 | US7683162 dissolving azithromycin in a solution containing ethanol, adding the dissolved azithromycin into water to precipitate the crystals, isolating and drying the precipitate; storage stability, free of organic solvents ; 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin |
| 03/23/2010 | US7683161 Catalytic hydrogenation |
| 03/18/2010 | WO2010029913A1 Mental vigor improver |
| 03/18/2010 | US20100068785 Spinosyn-producing polyketide synthases |
| 03/17/2010 | EP2163555A1 New pyrazole derivatives and diabetic medicine containing them |
| 03/17/2010 | EP1685120B1 Colouring hydrosoluble yellow preparation derived from dihydrochalcones |
| 03/17/2010 | EP1091971B1 Polyketide synthesis |
| 03/17/2010 | CN101671381A Method for preparing erythromycin |
| 03/17/2010 | CN101671325A Pronephrium megacuspe compound, preparation method thereof and application |
| 03/16/2010 | US7678773 Salts of avermectins substituted in the 4″-position and having pesticidal properties |
| 03/16/2010 | US7678740 Avermectin and avermectin monosaccharide derivatives substituted in the 4″-or 4′-position having pesticidal properties |
| 03/11/2010 | WO2010027108A1 Fluorescent sugar derivative compound and sensor using same |
| 03/11/2010 | US20100063124 New pyrazole derivatives and diabetic medicine containing them |
| 03/11/2010 | US20100062971 such as 2-{3-[2-(4-Methoxy-phenyl)-ethyl]-6-methyl-1H-indazol-4-yloxy} beta -D-glucopyranoside, used for for treating diabetes, Syndrome X, obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, polycystic ovarian syndrome, hypertension, ischemia, stroke and cardiovascula disorders |
| 03/11/2010 | US20100062492 Method For Preparing Icariside II, Cosmetic Composition Containing The Same and the Use Thereof For Skin Whitening |
| 03/03/2010 | CN101663312A Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof |
| 03/03/2010 | CN101659685A Method for removing pigment in spinosad fermentation liquid |
| 03/02/2010 | US7670836 Antimicrobial peptide isolated from Penaeus monodon |
| 02/25/2010 | US20100048882 N-(7-((3aR,4R,7R,7aR)-7-methoxy-6,6-dimethyl-2-oxo-tetrahydro-3aH- [1,3]dioxolo[4,5-c]pyran-4-yloxy)-2-oxo-2H-chromen-3-yl)acetamide; heat shock protein 90 inhibitors; gene expression inhibition; anticarcinogenic agents; neuroprotective agents |
| 02/25/2010 | US20100048494 Natural Products from Vinca |
| 02/24/2010 | EP0861261B9 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 02/24/2010 | CN201410309Y Avermectin extracting tank |
| 02/24/2010 | CN100591225C Composition containing isoflavone of high concentration and having high solubility, and process for producing the same |
| 02/23/2010 | US7666848 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 02/18/2010 | US20100041618 6-11 Bridged Oxime Erythromycin Derivatives |
| 02/18/2010 | US20100041568 Tripodal cyclohexane derivatives and their use as carbohydrate receptors |
| 02/17/2010 | CN101648983A 4''-substituted 13-cyclo-aza-lactone derivative |
| 02/16/2010 | US7662803 Such as polyoxyethylene, polyacrylamide homopolymers/copolymers with adrenergic agonists, narcotic and non-narcotic analgesics |
| 02/16/2010 | US7662802 Halide-free glucosamine-acidic drug complexes |
| 02/11/2010 | WO2010016587A1 Method for evaluating specific incorporation of d-glucose into cells |
| 02/11/2010 | US20100035832 Macrolides |
| 02/11/2010 | US20100034762 Novel enrichment methods for gallic acid esters including 1-O-galloy1-bata-D-glucose and mucic acid gallates medicaments, therapeutic applications and methods of treatment thereof |
| 02/10/2010 | CN101643490A Epothilonoside compound, preparation method and application as cytostatics thereof |
| 02/10/2010 | CN101643489A Process for preparing hesperidin |
| 02/09/2010 | CA2466358C Method for the production of desclarithromycin, and intermediate products |
| 02/04/2010 | US20100029919 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 02/04/2010 | US20100029918 Novel polyphenol glycoside isolated from acerola |
| 02/04/2010 | US20100028970 Medium for the Production of Tiacumicin B |
| 02/03/2010 | EP2149580A1 Mimetics of sulfated oligosaccharides |
| 02/03/2010 | CN101638424A Derivatives of astilbin and preparation method thereof |
| 02/02/2010 | US7655769 Orthogonally protected disaccharide building blocks for synthesis of heparin |
| 02/02/2010 | US7655768 Galactose derivative, drug carrier and medicinal composition |
| 02/02/2010 | US7655633 Beta-D-Glucopyranosyloxy)-3-(3-fluoro-4-methylbenzyl)-4,6-dimethylpyridine; sodium glucose co-transporter 2 (SGLT2) inhibitors; excellent hypoglycemic effect by excreting excess glucose into the urine through preventing the reabsorption of glucose at the kidney; antidiabetic agents; hyperglycemia |
| 02/02/2010 | US7655632 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 01/28/2010 | WO2003061603A9 Global suppressors of p53 mutations |
| 01/27/2010 | CN101633680A Process method for using ceramic membrane to replace alcohol sediment in separating puerarin |
| 01/27/2010 | CN100584854C Efficient parts of hydrangea paniculata, their preparing method and compositions and use thereof |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/21/2010 | WO2010006982A1 Mimetics of sulfated oligosaccharides |
| 01/21/2010 | US20100016956 Triazole compounds and methods of making and using the same |
| 01/21/2010 | US20100016955 Triazole compounds and methods of making and using the same |
| 01/20/2010 | EP1506214B1 6-11 bicyclic ketolide derivatives |
| 01/20/2010 | EP1338603B1 Novel pyrazole derivatives and diabetes remedies containing the same |
| 01/20/2010 | CN101631795A Erythromycin-based macrolides |
| 01/20/2010 | CN101628926A Extraction process of paeoniflorin |
| 01/20/2010 | CN100582116C Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof |
| 01/19/2010 | US7649099 two step processes of producing isosorbide from sorbitol; first step in presence of a solid acid catalyst; second step in presence of a second catalyst selected from sulfuric acid, phosphoric acid, hydrochloric acid and p-toluenesulfonic acid; cost efficiency, environmentally friendly; therapeutic uses |
| 01/14/2010 | WO2010003319A1 Hydrates of erythromycin salts, the preparation and the use thereof |
| 01/14/2010 | WO2009105507A3 Beloxepin, its enantiomers, and analogs thereof for the treatment of pain |
| 01/14/2010 | US20100009900 2-{3-[2-(2,3-Dihydro-benzofuran-5-yl)-ethyl]-1H-indol-4-yloxy} beta -D-glucopyranoside; sodium glucose transporter inhibitor; antidiabetic agent; Syndrome X, obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, hypertension, ischemia, stroke, heart disease, irritable bowel disorder, cataracts |
| 01/13/2010 | EP2143420A1 Formulation comprising mutant/s of lysosomal alpha-galactosidase A for the treatment of Fabry disease |
| 01/13/2010 | EP0723548B1 Phosphorescent compounds for imaging tissue oxygen |
| 01/13/2010 | CN101624413A Chalcomycin compounds and preparation and application of same |
| 01/13/2010 | CN101624412A Derivative of macrolides, method for preparing same and application thereof |
| 01/12/2010 | US7645864 N-demethyl-N-isopropyl-12-methoxy-11-oxo-8,9-anhydroerythromyc in A-6,9-hemiacetal fumarate; treating with ethyl acetate; reduced content of residual solvent and high suitability for formulation |
| 01/12/2010 | US7645863 Adding a second organic solvent to a concentrated moxidectin solution to obtain a weight ratio of 2:I to 6:I with respect to the first solvent; cooling and recovering crystals of 94-96% purity being 2-5% purer than the amorphous form; veterinary medicine; antithelmintics; parasiticides |
| 01/12/2010 | US7645787 4'-((2-fluoro-4-methylphenyl)methyl)-1'-isopropyl-5'-methyl-1H-pyrazole-3'-O-(6-carbomethoxy)- beta -D-glucopyranoside; 4-[(3-fluoro-4-methoxyphenyl)methyl]-1-isopropyl-5-methyl-1H-pyrazole-3-O- beta -D-glucopyranoside; reducing reanal glucose reabsorption |
| 01/12/2010 | CA2483678C 6-11 bicyclic ketolide derivatives |
| 01/07/2010 | US20100004188 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides |
| 01/07/2010 | US20100004160 Substituted fused heterocyclic c-glycosides |
| 01/07/2010 | US20100003221 Medium Supplement for Virus Production |
| 01/06/2010 | CN101619085A Erythromycin derivative and application as tumor cell proliferation inhibitor thereof |
| 01/06/2010 | CN100577681C Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/06/2010 | CN100577678C Macrolide analogue drug double sidechain illotycin A derivative, synthesis method and uses |
| 01/06/2010 | CN100577677C Caulis trachelospermi total lignans extractive, extraction method and medicine use of the active constituent thereof |
| 01/06/2010 | CN100577176C Extractive of Chinese globeflower in short petal, effective content of anti inflammation and usage |
| 01/05/2010 | CA2425319C Treatment and prophylaxis of diseases and infections of pigs and poultry |
| 12/31/2009 | US20090324577 6-11 Bicyclic Ketolide Derivatives |
| 12/30/2009 | WO2009156938A2 A cost effective process for preparing 6,9-imino ether |